Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Gross Margin (2016 - 2025)

Historic Gross Margin for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to 64.65%.

  • Bio-Techne's Gross Margin fell 6300.0% to 64.65% in Q4 2025 from the same period last year, while for Dec 2025 it was 65.22%, marking a year-over-year decrease of 4100.0%. This contributed to the annual value of 64.8% for FY2025, which is 16100.0% down from last year.
  • Latest data reveals that Bio-Techne reported Gross Margin of 64.65% as of Q4 2025, which was down 6300.0% from 65.65% recorded in Q3 2025.
  • Over the past 5 years, Bio-Techne's Gross Margin peaked at 8979.75% during Q3 2022, and registered a low of 62.72% during Q2 2025.
  • For the 5-year period, Bio-Techne's Gross Margin averaged around 512.46%, with its median value being 67.47% (2022).
  • Per our database at Business Quant, Bio-Techne's Gross Margin surged by 89134000bps in 2022 and then tumbled by -89128800bps in 2023.
  • Quarter analysis of 5 years shows Bio-Techne's Gross Margin stood at 68.22% in 2021, then decreased by -1bps to 67.52% in 2022, then decreased by -4bps to 64.78% in 2023, then increased by 1bps to 65.27% in 2024, then fell by -1bps to 64.65% in 2025.
  • Its Gross Margin was 64.65% in Q4 2025, compared to 65.65% in Q3 2025 and 62.72% in Q2 2025.